In this review, we discuss recent advances in our understanding of the role and mechanism of CCAR2 as a key coregulator of TFs and epigenetic modifiers, paying special attention given to the dual role of CCAR2 as a tumor suppressor and tumor promoter during tumorigenesis. The gene discussed is CCAR2; the disease is neoplasm.